Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 41431
                    [Title] => How to legally kill Filipinos and profit from it
                    [Summary] => 
            
                    [DatePublished] => 2008-01-29 00:00:00
                    [ColumnID] => 133540
                    [Focus] => 0
                    [AuthorID] => 1790869
                    [AuthorName] => William M. Esposo
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 174812
                    [Title] => Device offers longer-term solution for coronary artery disease
                    [Summary] => A breakthrough heart device now answers the long-time woes of patients suffering from coronary artery disease (CAD). 


Johnson & Johnson Medical Phils. recently launched its Cypher Sirolimus-eluting Stent in local hospitals. This is the first and only drug-coated stent approved by the Bureau of Food and Drugs (BFAD) for treatment of narrowed coronary arteries.


An industry first, the Cypher Sirolimus-eluting Stent is a new medical device that addresses one of the most stubborn problems in coronary artery disease treatment – the potential for restenosis. 


                    [DatePublished] => 2002-09-05 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

SIROLIMUS

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 41431
                    [Title] => How to legally kill Filipinos and profit from it
                    [Summary] => 
            
                    [DatePublished] => 2008-01-29 00:00:00
                    [ColumnID] => 133540
                    [Focus] => 0
                    [AuthorID] => 1790869
                    [AuthorName] => William M. Esposo
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 174812
                    [Title] => Device offers longer-term solution for coronary artery disease
                    [Summary] => A breakthrough heart device now answers the long-time woes of patients suffering from coronary artery disease (CAD). 


Johnson & Johnson Medical Phils. recently launched its Cypher Sirolimus-eluting Stent in local hospitals. This is the first and only drug-coated stent approved by the Bureau of Food and Drugs (BFAD) for treatment of narrowed coronary arteries.


An industry first, the Cypher Sirolimus-eluting Stent is a new medical device that addresses one of the most stubborn problems in coronary artery disease treatment – the potential for restenosis. 


                    [DatePublished] => 2002-09-05 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

abtest

How to legally kill Filipinos and profit from it

By AS I WRECK THIS CHAIR | By William M. Esposo | January 29, 2008 - 12:00am

Opinion

Device offers longer-term solution for coronary artery disease

September 5, 2002 - 12:00am

A breakthrough heart device now answers the long-time woes of patients suffering from coronary artery disease (CAD). Johnson & Johnson Medical Phils. recently launched its Cypher Sirolimus-eluting Stent in...

Science and Environment